Inventor profile of:

Dror MEVORACH

City:

Jerusalem

Country:

Israel

Published Applications:

25

Last publication date:

2025-08-14

Top Assignees for applications by Dror MEVORACH

The entities that hold a legal rights for patent applications filed by inventor MEVORACH Dror:

Recent patent applications by MEVORACH Dror

Dror MEVORACH from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-14
US20250255901A1
Human necessities

THERAPEUTIC APOPTOTIC CELLS FOR TREATMENT OF OSTEOARTHRITIS

#2 | 2023-03-23
US20230089828A1
Human necessities

USE OF EARLY APOPTOTIC CELLS FOR TREATING COVID-19

#3 | 2023-03-16
US20230084027A1
Chemistry; metallurgy

COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT

#4 | 2022-09-08
US20220280563A1
Human necessities

THERAPEUTIC APOPTOTIC CELLS FOR TREATMENT OF OSTEOARTHRITIS

#5 | 2022-05-05
US20220133799A1
Human necessities

Early apoptotic cells for use treating sepsis

#6 | 2021-07-29
US20210228633A1
Human necessities

COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT

#7 | 2021-04-15
US20210106617A9
Human necessities

COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT

#8 | 2021-02-11
US20210038644A1
Human necessities

Therapeutic pooled blood apoptotic cell preparations and uses thereof

#9 | 2020-09-17
US20200289557A1
Human necessities

Early apoptotic cells for use in treating sepsis

#10 | 2020-04-23
US20200121718A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#11 | 2020-02-27
US20200061116A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#12 | 2020-01-09
US20200009192A1
Human necessities

Therapeutic apoptotic cells for cancer therapy

#13 | 2020-01-09
US20200009191A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#14 | 2019-11-14
US20190345447A1
Chemistry; metallurgy

DENDRITIC CELL PREPARATIONS, COMPOSITIONS THEREOF AND METHODS OF USING SAME

#15 | 2019-06-13
US20190175649A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#16 | 2019-03-21
US20190083535A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#17 | 2019-01-24
US20190024048A1
Chemistry; metallurgy

Therapeutic apoptotic cell preparations, method for producing same and uses thereof

#18 | 2018-04-19
US20180104277A1
Human necessities

Therapeutic pooled blood apoptotic cell preparations and uses thereof

#19 | 2018-04-05
US20180094244A1
Chemistry; metallurgy

Combination immune therapy and cytokine control therapy for cancer treatment

#20 | 2017-12-21
US20170360836A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#21 | 2015-10-01
US20150275175A1
Chemistry; metallurgy

Therapeutic apoptotic cell preparations, method for producing same and uses thereof

#22 | 2015-02-26
US20150056678A1
Chemistry; metallurgy

Method of preparing apoptotic monocytes

#23 | 2010-10-07
US20100255003A1
Chemistry; metallurgy

Immune disease medicament comprising a modulator of the binding between a heparin binding domain of thrombospondin-1 and a beta1 integrin

#24 | 2005-09-15
US20050202098A1
Chemistry; metallurgy

Disease therapy using dying or dead cells

#25 | 2005-02-10
US20050031618A1
Human necessities

Induction of tolerance by apoptotic and/or necrotic cells

InventorID:

1079401 ⎘